SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 13F-HR - Quarterly report filed by institutional managers, Holdings:
SEC Accession No. 0001012975-24-000204
Filing Date
2024-05-14
Accepted
2024-05-14 16:07:50
Documents
2
Period of Report
2024-03-31
Effectiveness Date
2024-05-14

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 13F-HR  
1 primary_doc.xml 13F-HR 2414
2 INFORMATION TABLE infotable.html INFORMATION TABLE  
2 INFORMATION TABLE infotable.xml INFORMATION TABLE 6483
  Complete submission text file 0001012975-24-000204.txt   10122
Mailing Address 501 2ND ST, SUITE 200 SAN FRANCISCO CA 94107
Business Address 501 2ND ST, SUITE 200 SAN FRANCISCO CA 94107 415-948-7474
Pivotal bioVenture Partners Investment Advisor LLC (Filer) CIK: 0001844645 (see all company filings)

IRS No.: 814749159 | State of Incorp.: DE
Type: 13F-HR | Act: 34 | File No.: 028-20630 | Film No.: 24944335